Good morning and good afternoon, and welcome to the Novartis Q4 2024 results release conference call and live webcast.

During 2024, the radiopharmaceutical Pluvicto achieved blockbuster status, while sales of the breast cancer drug Kisqali grew 46 percent compared to 2023.

Distant-stage prostate cancer increased and mortality rates plateaued throughout California during the 2010s, according to a ...

The urine test “now empowers patients to collect their samples in the comfort of their homes, a significant step forward in ...

Longtime Chicago radio star known for "Disco Demolition" is preparing for radiation treatment but says he doesn't plan to ...

(RTTNews) - RedHill Biopharma (RDHL) Tuesday announced that it has launched a Phase 2 trial to assess opaganib's ability to enhance darolutamide in treating metastatic castrate-resistant prostate ...

Researchers at Vanderbilt have found a simple at home urine test for prostate cancer screening is highly accurate. The ...

Jan. 15, 2025 – Prostate cancer is quite common – over 60% of those diagnosed are men over the age of 65 – but it’s not a high priority for cancer researchers. One big reason ...

Prostate cancer is now the most common cancer in the UK, according to new analysis - as a leading charity renewed its calls for a national screening program. NHS data found 55,033 men were ...

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical trials for ovarian and bile duct cancer, according to research ...

But the location of the cancer in the prostate could be anywhere, which would seem to be difficult to direct the treatment probe to. SquareStem January 10, 2025 06:23 AM ...

Black men are "put in disproportionate danger of dying" from prostate cancer due to health inequities and outdated NHS guidelines, a leading charity has said. Prostate Cancer UK says that black ...